MassMutual Private Wealth & Trust FSB Has $24.09 Million Stake in Stryker Corporation $SYK

MassMutual Private Wealth & Trust FSB lowered its position in Stryker Corporation (NYSE:SYK) by 5.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 68,553 shares of the medical technology company’s stock after selling 4,322 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in Stryker were worth $24,094,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Clayton Financial Group LLC bought a new stake in Stryker during the 3rd quarter worth approximately $26,000. United Financial Planning Group LLC bought a new position in Stryker in the 3rd quarter valued at $27,000. Elevation Point Wealth Partners LLC acquired a new position in Stryker in the second quarter worth $28,000. Kilter Group LLC acquired a new position in Stryker in the second quarter worth $29,000. Finally, Howard Hughes Medical Institute acquired a new stake in shares of Stryker in the second quarter valued at $29,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on SYK shares. Wall Street Zen raised Stryker from a “hold” rating to a “buy” rating in a report on Saturday, February 21st. Weiss Ratings restated a “hold (c+)” rating on shares of Stryker in a research report on Monday, December 22nd. BTIG Research boosted their target price on shares of Stryker from $410.00 to $412.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. Jefferies Financial Group reiterated a “buy” rating and set a $465.00 target price on shares of Stryker in a research report on Wednesday, March 4th. Finally, Evercore set a $390.00 price target on shares of Stryker in a research note on Monday, January 5th. Fourteen investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and a consensus target price of $427.50.

Insider Buying and Selling at Stryker

In related news, Director Ronda E. Stryker sold 250,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the sale, the director directly owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. The trade was a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 5.90% of the stock is currently owned by company insiders.

Stryker Trading Down 1.1%

Shares of SYK opened at $335.96 on Friday. The stock’s fifty day simple moving average is $363.25 and its 200-day simple moving average is $366.04. The firm has a market capitalization of $128.57 billion, a PE ratio of 39.99, a price-to-earnings-growth ratio of 1.99 and a beta of 0.85. Stryker Corporation has a 12-month low of $328.23 and a 12-month high of $404.87. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. The firm had revenue of $7.17 billion during the quarter, compared to analyst estimates of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The company’s revenue was up 11.4% on a year-over-year basis. During the same period last year, the company earned $4.01 earnings per share. As a group, research analysts predict that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.88 per share. The ex-dividend date is Tuesday, March 31st. This represents a $3.52 annualized dividend and a dividend yield of 1.0%. Stryker’s payout ratio is currently 41.90%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.